Division of Hematology/Oncology

Gastrointestinal (GI) Cancer Program

Penn Medicine's gastrointestinal cancer specialists and researchers are leading the way nationally in the diagnosis and treatment of gastrointestinal malignancies. Penn's Gastrointestinal Cancer Program has extensive experience in managing cancers of the GI tract, including esophagogastric, pancreatobiliary, colorectal, hepatocellular, and neuroendocrine tumors as well as rare gastrointestinal tumors.

A Multidisciplinary Approach to Care

Patients with GI cancers are seen within the GI Cancer Program, by a multidisciplinary team that includes medical, surgical and radiation oncologists, gastroenterologists, interventional radiologists, nutritionists, and oncology support specialists. Patients with GI cancers at Penn also benefit from specialized resources offered through the Abramson Cancer Center, including cancer counseling, pain management, cancer fatigue rehabilitative services, and educational conferences. The Abramson Cancer Center is a National Cancer Institute (NCI) designated comprehensive cancer center that is rated as "exceptional" after its most recent peer review.

Each week, members of the patient's team meet to discuss treatment strategies for the patient ensuring that each individual gets a personalized treatment plan designed for them. This collaboration ensures that care is taken of the patient as a whole, not just the disease.

Gastrointestinal (GI) Cancer Services

Penn Hematology/Oncology services for GI cancer at Penn include:

  • Multidisciplinary evaluation
  • Advanced diagnostic testing, treatments and technologies
  • Coordinated care throughout the experience

The Penn Difference

Penn's Gastrointestinal Cancer Program has nationally recognized experts in the field of gastrointestinal cancer care.

  • Patients within the GI cancer program have access to the latest clinical trials including targeted cancer agents and immunotherapies, which may have fewer side effects than traditional cancer therapies. Penn also offers early phase studies that are well suited to GI cancer patients.
  • Prominent cancer researchers at Penn are conducting studies funded by the National Cancer Institute on the causes of GI cancers, risk factors, and treatment advances, thereby ensuring that the latest discoveries are immediately translated to improved patient outcomes.
  • Penn's Gastrointestinal Cancer Program is adept at managing complex patients with concurrent medical problems.

Gastrointestinal Cancer Team

Penn hematologists/oncologists who specialize in GI cancer include:

Loading Provider List...

Learn more about the Gastrointestinal (GI) Cancer Program